Error: Could not add to watchlist. X
+ Watchlist

Allianz Global Investors Global Biotech Fund

DREGBIO:TT
33.58
TWD
As of 12:00 AM EDT 4/27/2017
Fund Type
Open-End Fund
52Wk Range
29.29 - 35.50
1 Yr Return
2.60%
YTD Return
6.17%
Before it's here, it's on the Bloomberg Terminal.
Learn More
52Wk Range
29.29 - 35.50
1 Yr Return
-0.18%
YTD Return
6.17%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 04/27/2017)
33.58
Total Assets (b TWD) (on 03/31/2017)
5.610
Inception Date
06/28/2002
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
HSU CHIH-WEI
Front Load Fee
2.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.80%
Expense Ratio
-

Top Fund Holdings

Name Position Value % of Fund
92.18 k 493.29 m 0.00
42.34 k 468.60 m 0.00
115.27 k 417.82 m 0.00
98.08 k 394.52 m 0.00
110.41 k 291.35 m 0.00
87.48 k 234.69 m 0.00
126.90 k 233.92 m 0.00
98.53 k 209.65 m 0.00
43.79 k 176.59 m 0.00
256.44 k 170.52 m 0.00
Profile
Allianz Global Investors Global Biotech Fund is an open-end unit trust establish ed in Taiwan. The Fund's objective is to seek long-term capital gain and secure stable income. The Fund invests primarily in equity securities issued by companies in the biotechnology sector. It also invests in local equities and government bonds (including convertibles) and financial debentures.
Address
Allianz Global Investors Taiwan Ltd
6F 378 Fu Shin North Road
Taipei
Taiwan
Phone
886-2-2502-8889